220 related articles for article (PubMed ID: 12027416)
21. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
22. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
Ohashi Y; So SK; Minasi PN; Tabbara KF
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
[TBL] [Abstract][Full Text] [Related]
23. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB
Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159
[TBL] [Abstract][Full Text] [Related]
24. The protein kinase C system in focal adenitis of the lacrimal gland in the non-obese diabetic mouse model for Sjögren's syndrome.
Tensing EK; Törnwall J; Hukkanen M; Nordström DC; Konttinen YT
Acta Ophthalmol Scand; 2004 Oct; 82(5):569-73. PubMed ID: 15453855
[TBL] [Abstract][Full Text] [Related]
25. Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57Bl/6-lpr/lpr mice.
Fleck M; Kern ER; Zhou T; Lang B; Mountz JD
Arthritis Rheum; 1998 Dec; 41(12):2175-84. PubMed ID: 9870874
[TBL] [Abstract][Full Text] [Related]
26. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
27. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
28. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
29. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
30. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice.
Fujita H; Fujihara T; Takeuchi T; Saito I; Tsubota K
Adv Exp Med Biol; 1998; 438():941-8. PubMed ID: 9634991
[No Abstract] [Full Text] [Related]
31. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model.
Killian M; Colaone F; Haumont P; Nicco C; Cerles O; Chouzenoux S; Cathébras P; Rochereau N; Chanut B; Thomas M; Laroche N; Forest F; Grouard-Vogel G; Batteux F; Paul S
Front Immunol; 2021; 12():666134. PubMed ID: 34867938
[TBL] [Abstract][Full Text] [Related]
33. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
34. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
Sullivan DA; Edwards JA
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
[TBL] [Abstract][Full Text] [Related]
35. Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus.
Nguyen C; Singson E; Kim JY; Cornelius JG; Attia R; Doyle ME; Bulosan M; Cha S; Peck AB
Scand J Immunol; 2006 Sep; 64(3):295-307. PubMed ID: 16918699
[TBL] [Abstract][Full Text] [Related]
36. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
38. The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice.
Bloch DB; Rabkina D; Bloch KD
Lab Invest; 1995 Sep; 73(3):366-71. PubMed ID: 7564269
[TBL] [Abstract][Full Text] [Related]
39. Keratoconjunctivitis sicca.
Baum JL
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(4 Pt 1):OP619-23. PubMed ID: 960384
[TBL] [Abstract][Full Text] [Related]
40. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
